Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Moody Longevity Trial: Tirzepatide to Slow Biological Aging
Authors not listed
The University of Texas Medical Branch, Galveston · 2026
Abstract
This pilot clinical study aims to investigate the potential effects of tirzepatide on biological aging in older adults. In this novel study, 90 adults aged 55-70 years with an indication for tirzepatide weight-loss therapy will be randomized to receive either tirzepatide 2.5 mg subcutaneously (SC) weekly or no drug for 24 weeks, followed by 12 weeks off the drug. Since tirzepatide is already recognized as a highly effective weight-loss agent in this population, the primary focus will not be on measuring weight loss. Instead, the study will document the effects of tirzepatide on markers of aging, physical function, and overall health.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Anonymous. (2026). The Moody Longevity Trial: Tirzepatide to Slow Biological Aging. <em>The University of Texas Medical Branch, Galveston</em>. https://clinicaltrials.gov/study/NCT07220473
Vancouver
Anonymous. The Moody Longevity Trial: Tirzepatide to Slow Biological Aging. The University of Texas Medical Branch, Galveston. 2026.
BibTeX
@misc{anon2026TheMoo,
title = {The Moody Longevity Trial: Tirzepatide to Slow Biological Aging},
author = {Anonymous},
journal = {The University of Texas Medical Branch, Galveston},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
EUROPEAN LIFE SCIENCE RESEARCH ASSOCIATION 2026
Open access · US-GOV
A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effects of NVTIA® Ergothioneine Supplementation on Healthy Aging Biomarkers and Skin Health in Healthy Adults
Mayo Clinic 2026
Open access · US-GOV
The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity: A Pilot Study
Buck Institute for Research on Aging 2022
Open access · US-GOV
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Feasibility Pilot Study to Evaluate the Tolerability and Safety of a Novel Ketone Ester Ingredient in Healthy Older Men and Women.
Zheng Li 2026
Open access · US-GOV
Effects and Mechanisms of a Virtual Reality-Based Multidomain Intervention in Older Adults With Cognitive Frailty: A Randomized Controlled Trial
F1000Research 2024
Open access · CC-BY
Peer Review Report For: Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders [version 1; peer review: 2 approved with reservations]
F1000Research 2024
Open access · CC-BY